Read articles from United States of America

August 11, 2026 by planetofthevapes.co.uk

Science should be able to correct itself — that is part of its strength. In nicotine policy, the problem comes when early claims are treated as settled truth long after the evidence has moved on. Corrections matter because public understanding of vaping, risk and smoking is shaped by what researchers, media and regulators choose to repeat. Public health should be willing to update its message when the data no longer supports the alarm.

August 10, 2026 by umaryland.edu

The central comparison is not between vaping and doing nothing. It is between the risks of e-cigarettes and the far greater harms of continued smoking. For adults who smoke, the benefits of stopping combustible tobacco can substantially outweigh the uncertainties associated with switching to lower-risk nicotine products. Public health advice should make that hierarchy clear: quit smoking completely where possible, but do not let fear of imperfect alternatives keep people using cigarettes.

August 10, 2026 by umaryland.edu

The central comparison is not between vaping and doing nothing. It is between the risks of e-cigarettes and the far greater harms of continued smoking. For adults who smoke, the benefits of stopping combustible tobacco can substantially outweigh the uncertainties associated with switching to lower-risk nicotine products. Public health advice should make that hierarchy clear: quit smoking completely where possible, but do not let fear of imperfect alternatives keep people using cigarettes.

August 10, 2026 by regulatorwatch.com

Nicotine-free vapes show how easily regulation can drift from risk assessment into guilt by association. A product does not become equivalent to smoking simply because it sits near nicotine in the public debate. If rules are based on category suspicion rather than exposure, use and actual harm, they risk confusing consumers and weakening trust in public health. Regulation should be precise enough to distinguish what products contain, how they are used and what risks they genuinely present.

August 10, 2026 by regulatorwatch.com

Nicotine-free vapes show how easily regulation can drift from risk assessment into guilt by association. A product does not become equivalent to smoking simply because it sits near nicotine in the public debate. If rules are based on category suspicion rather than exposure, use and actual harm, they risk confusing consumers and weakening trust in public health. Regulation should be precise enough to distinguish what products contain, how they are used and what risks they genuinely present.

August 07, 2026 by clearingtheair.eu

The movement away from smoking is already happening in the data. A study showing exclusive vaping rising by 18.8% a year among US adults suggests that many people are not simply adding nicotine products, but replacing cigarettes with smoke-free alternatives. That distinction matters: full switching is where harm reduction has the greatest potential. Policy should pay attention to these behavioural shifts instead of treating all nicotine use as a failure.

August 07, 2026 by substack.com

Regulatory meetings should be judged by whether they bring public health closer to real-world solutions. Responses to the FDA’s tobacco regulatory agenda show how wide the gap remains between precaution, evidence and the needs of adults who smoke. If the process treats lower-risk nicotine products mainly as a threat, it risks missing their potential role in reducing exposure to combustible tobacco. Better regulation starts with listening to evidence, consumers and unintended consequences — not only institutional caution.

August 06, 2026 by tobaccoreporter.com

Doctors are often the first trusted voice a smoker hears when trying to quit. If evidence supports vaping as a cessation aid, clinicians should be able to discuss it honestly rather than avoid the subject because of stigma. The goal is not to promote nicotine use, but to help people move away from combustible tobacco when other methods have not worked. Smoking cessation advice should reflect the full range of evidence-based options available to adults.

July 31, 2026 by healthday.com

Cancer risk should not be discussed through headlines alone. New modelling on vaping and future cancer burden raises important questions about long-term outcomes, but it also depends on the comparison being made: continued smoking, complete cessation, dual use or full switching. The crucial distinction remains combustion, which drives the overwhelming burden of tobacco-related cancer. Public health communication should examine emerging risks without obscuring the far greater danger of cigarettes.

July 31, 2026 by medicalxpress.com

A lower-nicotine cigarette may change the product, but it does not remove the need for a serious quit conversation. Smokers still need clear support, realistic options and honest information about why burning tobacco causes so much harm. Any move to reduce nicotine in cigarettes should be paired with access to effective cessation tools, including lower-risk nicotine alternatives where appropriate. Otherwise, policy may weaken dependence on paper while leaving people without a workable route away from smoking.